Bausch Health Companies (BHC) vs Eton Pharmaceuticals (ETON)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Eton Pharmaceuticals (ETON) has outperformed Bausch Health Companies (BHC) over the past year, gaining 159.5% versus a loss of 3.8%. Over five years, ETON leads with a +953.4% price change compared with -78.4% for BHC. Bausch Health Companies is the larger company by market cap ($2.30 billion vs $1.56 billion), about 1.5 times the size.
On valuation, Bausch Health Companies trades at a lower forward P/E (1.5x vs 21.1x for Eton Pharmaceuticals).
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BHC | ETON |
|---|---|---|
| Share price | $6.14 | $54.50 |
| Market cap | $2.30B | $1.56B |
| 1-day change | -0.16% | -0.70% |
| YTD return | -11.51% | +224.54% |
| 1-year return | -3.76% | +159.48% |
| 5-year return | -78.41% | +953.36% |
| P/E ratio (TTM) | — | 136.24 |
| Forward P/E | 1.46 | 21.12 |
| EPS (TTM) | $-2.95 | $0.40 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $8.00 | $66.37 |
| 52-week low | $4.33 | $14.27 |
| Distance from 52-week high | -23.25% | -17.89% |
| Analyst consensus | hold | strong_buy |
| Avg. price target upside | +22.15% | +30.29% |
| Average volume | 3.24M | 606.07K |
| Shares outstanding | 373.99M | 28.58M |
| Employees | 20,300 | 44 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- ETON has outperformed BHC by 163.2 percentage points over the past year.
About Bausch Health Companies
BHC stock →Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company.
Health Care · Biotechnology: Pharmaceutical Preparations · 20,300 employees
About Eton Pharmaceuticals
ETON stock →Eton Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing treatments for rare diseases. Its commercial rare disease products include Increlex for the treatment of severe primary igf-1 deficiency; Alkindi Sprinkle for adrenal insufficiency; Khindivi for adrenocortical insufficiency; Galzin for Wilson disease; PKU Golike for phenylketonuria; Carglumic Acid for N-acetylglutamate synthase deficiency; Betaine Anhydrous for homocystinuria; and Nitisinone for tyrosinemia type 1.
Health Care · Biotechnology: Pharmaceutical Preparations · 44 employees
BHC vs ETON FAQ
Which is bigger, Bausch Health Companies or Eton Pharmaceuticals?
Bausch Health Companies (BHC) is larger, with a market capitalization of $2.30B compared with $1.56B for Eton Pharmaceuticals (ETON).
Which stock has performed better over the past year, BHC or ETON?
ETON returned +159.48% over the past 12 months, compared with -3.76% for BHC (price return, excluding dividends). Past performance does not predict future results.
Are Bausch Health Companies and Eton Pharmaceuticals in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.